Loading
ROKSTUDIOS

Why Scalability is Now Integral for Bolstering Efficiency in the Pharmaceutical Sector

Dirk Schuster joins Stan Miller in the ROKStudios

Share This:

LinkedInLinkedIn
XX
FacebookFacebook
PrintPrint
EmailEmail

Over the past few years, there has been an industry shift from mass batch production towards processing efficiency and scalability. In his ROKStudios session, Dirk Schuster, vice president for sales machinery at Groninger, explains why this has happened, and the benefits it brings with it.

Learn more here.

Watch more videos on our ROKStudios hub page.

Topics: Management Perspectives Food & Beverage Life Sciences
Subscribe

Subscribe to Rockwell Automation and receive the latest news, thought leadership and information directly to your inbox.

Subscribe
  1. Chevron LeftChevron Left Rockwell Automation Home
  2. Chevron LeftChevron Left Com...
  3. Chevron LeftChevron Left News
  4. Chevron LeftChevron Left ROKStudios
  5. Chevron LeftChevron Left Why Scalability is Now Integral for Bolstering Efficiency in the Pharmaceutical Sector
Please update your cookie preferences to continue.
This feature requires cookies to enhance your experience. Please update your preferences to allow for these cookies:
  • Social Media Cookies
  • Functional Cookies
  • Performance Cookies
  • Marketing Cookies
  • All Cookies
You can update your preferences at any time. For more information please see our {0} Privacy Policy
CloseClose